37371950|t|Liposome-Encapsulated Berberine Alleviates Liver Injury in Type 2 Diabetes via Promoting AMPK/mTOR-Mediated Autophagy and Reducing ER Stress: Morphometric and Immunohistochemical Scoring.
37371950|a|In the advanced stages of type 2 diabetes mellitus (T2DM), diabetic liver damage is a common complication that can devastate a patient's quality of life. The present study investigated the ability of liposomal berberine (Lip-BBR) to aid in ameliorating hepatic damage and steatosis, insulin homeostasis, and regulating lipid metabolism in type 2 diabetes (T2DM) and the possible pathways by which it does so. Liver tissue microarchitectures and immunohistochemical staining were applied during the study. The rats were divided into a control non-diabetic group and four diabetic groups, which are the T2DM, T2DM-Lip-BBR (10 mg/kg b.wt), T2DM-Vildagliptin (Vild) (10 mg/kg b.wt), and T2DM-BBR-Vild (10 mg/kg b.wt + Vild (5 mg/kg b.wt) groups. The findings demonstrated that Lip-BBR treatment could restore liver tissue microarchitectures, reduce steatosis and liver function, and regulate lipid metabolism. Moreover, Lip-BBR treatment promoted autophagy via the activation of LC3-II and Bclin-1 proteins and activated the AMPK/mTOR pathway in the liver tissue of T2DM rats. Lip-BBR also activated the GLP-1 expression, which stimulated insulin biosynthesis. It decreased the endoplasmic reticulum stress by limiting the CHOP, JNK expression, oxidative stress, and inflammation. Collectively, Lip-BBR ameliorated diabetic liver injury in a T2DM rat model with its promotion activity of AMPK/mTOR-mediated autophagy and limiting ER stress.
37371950	22	31	Berberine	Chemical	MESH:D001599
37371950	43	55	Liver Injury	Disease	MESH:D017093
37371950	59	74	Type 2 Diabetes	Disease	MESH:D003924
37371950	89	93	AMPK	Gene	78975
37371950	94	98	mTOR	Gene	56718
37371950	214	238	type 2 diabetes mellitus	Disease	MESH:D003924
37371950	240	244	T2DM	Disease	MESH:D003924
37371950	247	268	diabetic liver damage	Disease	MESH:D016640
37371950	398	407	berberine	Chemical	MESH:D001599
37371950	409	416	Lip-BBR	Chemical	-
37371950	441	455	hepatic damage	Disease	MESH:D056486
37371950	460	469	steatosis	Disease	MESH:D005234
37371950	507	512	lipid	Chemical	MESH:D008055
37371950	527	542	type 2 diabetes	Disease	MESH:D003924
37371950	544	548	T2DM	Disease	MESH:D003924
37371950	734	742	diabetic	Disease	MESH:D003920
37371950	758	766	diabetic	Disease	MESH:D003920
37371950	789	793	T2DM	Disease	MESH:D003924
37371950	795	799	T2DM	Disease	MESH:D003924
37371950	800	807	Lip-BBR	Chemical	-
37371950	825	829	T2DM	Disease	MESH:D003924
37371950	830	842	Vildagliptin	Chemical	MESH:D000077597
37371950	844	848	Vild	Chemical	-
37371950	871	875	T2DM	Disease	MESH:D003924
37371950	880	884	Vild	Chemical	-
37371950	902	906	Vild	Chemical	-
37371950	961	968	Lip-BBR	Chemical	-
37371950	1033	1042	steatosis	Disease	MESH:D005234
37371950	1076	1081	lipid	Chemical	MESH:D008055
37371950	1104	1111	Lip-BBR	Chemical	-
37371950	1163	1169	LC3-II	Gene	362245
37371950	1209	1213	AMPK	Gene	78975
37371950	1214	1218	mTOR	Gene	56718
37371950	1250	1254	T2DM	Disease	MESH:D003924
37371950	1261	1268	Lip-BBR	Chemical	-
37371950	1288	1293	GLP-1	Gene	24952
37371950	1407	1411	CHOP	Gene	29467
37371950	1413	1416	JNK	Gene	116554
37371950	1451	1463	inflammation	Disease	MESH:D007249
37371950	1479	1486	Lip-BBR	Chemical	-
37371950	1499	1520	diabetic liver injury	Disease	MESH:D017093
37371950	1526	1530	T2DM	Disease	MESH:D003924
37371950	1572	1576	AMPK	Gene	78975
37371950	1577	1581	mTOR	Gene	56718
37371950	Association	MESH:D001599	56718
37371950	Association	MESH:D017093	56718
37371950	Negative_Correlation	MESH:D001599	MESH:D017093
37371950	Positive_Correlation	MESH:D001599	78975
37371950	Negative_Correlation	MESH:D001599	MESH:D005234
37371950	Association	MESH:D017093	78975
37371950	Negative_Correlation	MESH:D001599	MESH:D056486
37371950	Negative_Correlation	MESH:D000077597	MESH:D003920
37371950	Negative_Correlation	MESH:D000077597	MESH:D003924
37371950	Association	MESH:D001599	MESH:D008055

